In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens
Antibiotics are majorly important molecules for human health. Following the golden age of antibiotic discovery, a period of decline ensued, characterised by the rediscovery of the same molecules. At the same time, new culture techniques and high-throughput sequencing enabled the discovery of new mic...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/335c42cedcb44aabae4c02720d7eadaf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:335c42cedcb44aabae4c02720d7eadaf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:335c42cedcb44aabae4c02720d7eadaf2021-11-25T18:24:55ZIn Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens10.3390/microorganisms91122972076-2607https://doaj.org/article/335c42cedcb44aabae4c02720d7eadaf2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-2607/9/11/2297https://doaj.org/toc/2076-2607Antibiotics are majorly important molecules for human health. Following the golden age of antibiotic discovery, a period of decline ensued, characterised by the rediscovery of the same molecules. At the same time, new culture techniques and high-throughput sequencing enabled the discovery of new microorganisms that represent a potential source of interesting new antimicrobial substances to explore. The aim of this review is to present recently discovered nonribosomal peptide (NRP) and polyketide (PK) molecules with antimicrobial activity against human pathogens. We highlight the different in silico/in vitro strategies and approaches that led to their discovery. As a result of technological progress and a better understanding of the NRP and PK synthesis mechanisms, these new antibiotic compounds provide an additional option in human medical treatment and a potential way out of the impasse of antibiotic resistance.Sami KhabthaniJean-Marc RolainVicky MerhejMDPI AGarticlenew NRP-PK antibioticsin silico/in vitro strategieshuman pathogensbottom-up approachBiology (General)QH301-705.5ENMicroorganisms, Vol 9, Iss 2297, p 2297 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
new NRP-PK antibiotics in silico/in vitro strategies human pathogens bottom-up approach Biology (General) QH301-705.5 |
spellingShingle |
new NRP-PK antibiotics in silico/in vitro strategies human pathogens bottom-up approach Biology (General) QH301-705.5 Sami Khabthani Jean-Marc Rolain Vicky Merhej In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens |
description |
Antibiotics are majorly important molecules for human health. Following the golden age of antibiotic discovery, a period of decline ensued, characterised by the rediscovery of the same molecules. At the same time, new culture techniques and high-throughput sequencing enabled the discovery of new microorganisms that represent a potential source of interesting new antimicrobial substances to explore. The aim of this review is to present recently discovered nonribosomal peptide (NRP) and polyketide (PK) molecules with antimicrobial activity against human pathogens. We highlight the different in silico/in vitro strategies and approaches that led to their discovery. As a result of technological progress and a better understanding of the NRP and PK synthesis mechanisms, these new antibiotic compounds provide an additional option in human medical treatment and a potential way out of the impasse of antibiotic resistance. |
format |
article |
author |
Sami Khabthani Jean-Marc Rolain Vicky Merhej |
author_facet |
Sami Khabthani Jean-Marc Rolain Vicky Merhej |
author_sort |
Sami Khabthani |
title |
In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens |
title_short |
In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens |
title_full |
In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens |
title_fullStr |
In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens |
title_full_unstemmed |
In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human Pathogens |
title_sort |
in silico/in vitro strategies leading to the discovery of new nonribosomal peptide and polyketide antibiotics active against human pathogens |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/335c42cedcb44aabae4c02720d7eadaf |
work_keys_str_mv |
AT samikhabthani insilicoinvitrostrategiesleadingtothediscoveryofnewnonribosomalpeptideandpolyketideantibioticsactiveagainsthumanpathogens AT jeanmarcrolain insilicoinvitrostrategiesleadingtothediscoveryofnewnonribosomalpeptideandpolyketideantibioticsactiveagainsthumanpathogens AT vickymerhej insilicoinvitrostrategiesleadingtothediscoveryofnewnonribosomalpeptideandpolyketideantibioticsactiveagainsthumanpathogens |
_version_ |
1718411186429493248 |